HES5 and breast cancer: Interestingly, when we analysed existing clinical breast cancer cohort data, we found that the high expression level of HES5, but not HES1 or HEY1 was significantly correlated with a poor brain metastasis-free survival of breast cancer patients (Fig 5B).